• About Us
    • Leadership
    • Our Supporters
    • IRS Form 990
  • Resources for Your Journey
    • What Is Heart Valve Disease?
    • Understanding Your Echocardiogram Results
    • News & Insights
    • HVV US Patient Journey Report
  • Events
  • Advocacy
    • Patient Spotlight Series
    • Apply to Be a Patient Ambassador
    • Share Your Story
    • Become an Advocate
    • HVD Policy Task Force
    • #Ask4Echo Campaign
  • Join Our Community
    • Sign Up For Our Mailing List
    • My Valve. My Voice.
Heart Valve Voice USHeart Valve Voice US
  • About Us
    • Leadership
    • Our Supporters
    • IRS Form 990
  • Resources for Your Journey
    • What Is Heart Valve Disease?
    • Understanding Your Echocardiogram Results
    • News & Insights
    • HVV US Patient Journey Report
  • Events
  • Advocacy
    • Patient Spotlight Series
    • Apply to Be a Patient Ambassador
    • Share Your Story
    • Become an Advocate
    • HVD Policy Task Force
    • #Ask4Echo Campaign
  • Join Our Community
    • Sign Up For Our Mailing List
    • My Valve. My Voice.

HVV US is advocating for patients with mitral valve disease. See our comments to CMS

Home Policy CenterHVV US is advocating for patients with mitral valve disease. See our comments to CMS

HVV US is advocating for patients with mitral valve disease. See our comments to CMS

August 7, 2020 Policy Center, Policy Statement


Telehealth offers significant advantages to patients of all types, including and especially older Americans with mobility and other age-associated health conditions. We believe telehealth is not a trend but an important tool to facilitate safe, convenient, efficient access for patients. The new minimum surgical procedure thresholds for both new and established TEER programs have no scientific basis, are anti-competitive, and only serve to limit patient access.
If the goals of simplified reporting, increased transparency, broader access, and greater utility cannot be accommodated through the current TVT Registry structure, then CMS should consider an alternative reporting mandate to a patient-centered registry.  

Read more on our comments below.  

HVVUS_TEER-Comment-1Download
Tags: CMSMitral Valve
Share
1

You also might be interested in

New Developments Expected in 2019 for Minimally Invasive Valve Treatments

Jan 3, 2019

Mitral Valve Positive Findings A minimally-invasive treatment option for mitral[...]

CMS Releases CY 2021 IPPS Proposed Rule

Jun 23, 2020

On May 12, the Centers for Medicare and Medicaid Services[...]

Watch Our Event: A Briefing on Emerging Issues in Mitral Valve Disease

Watch Our Event: A Briefing on Emerging Issues in Mitral Valve Disease

Feb 6, 2020

 Did you miss our briefing on Capitol Hill January[...]

Contact Us

Please contact us with any questions or to get involved.

Send Message
Join the My Valve My Voice patient community Download the app
Sign Up for Our Mailing List
  • facebook
  • x
  • linkedin

© · Heart Valve Voice

Terms of Use
Privacy Policy

Website Management provided by Genacom

Contact Info

  • Heart Valve Voice US
  • 100 M Street SE 600 Washington, DC 20003
  • info@heartvalvevoice-us.org
  • https://www.heartvalvevoice-us.org
Prev Next